Infarct Reduction Technologies Inc.
Non-invasive disposable device to improve heart attack treatment - reduces heart damage by up to 50% with large cost savings potential
IRT is set to capitalize on an important recent discovery that a therapy called “remote ischemic preconditioning” virtually eliminates reperfusion injury. As a result, it reduces heart attack damage by up to 50%. The therapy has been safely applied in over 60 studies on over 10,000 patients. Current manual delivery however limits its adoption. IRT is developing a patented, single-button automatic device to simplify its delivery.